Literature DB >> 33333932

Spliceosome Mutations in Uveal Melanoma.

Josephine Q N Nguyen1,2, Wojtek Drabarek1,2, Serdar Yavuzyigitoglu1,2, Eva Medico Salsench2, Robert M Verdijk3,4,5, Nicole C Naus1, Annelies de Klein2, Emine Kiliç1, Erwin Brosens2.   

Abstract

Uveal melanoma (UM) is the most common primary intraocular malignancy of the eye. It has a high metastatic potential and mainly spreads to the liver. Genetics play a vital role in tumor classification and prognostication of UM metastatic disease. One of the driver genes mutated in metastasized UM is subunit 1 of splicing factor 3b (SF3B1), a component of the spliceosome complex. Recurrent mutations in components of the spliceosome complex are observed in UM and other malignancies, suggesting an important role in tumorigenesis. SF3B1 is the most common mutated spliceosome gene and in UM it is associated with late-onset metastasis. This review summarizes the genetic and epigenetic insights of spliceosome mutations in UM. They form a distinct subgroup of UM and have similarities with other spliceosome mutated malignancies.

Entities:  

Keywords:  DNA repair; chromosomes; epigenetic; genetic; metastatic disease; mutational analysis; prognosis; therapy

Year:  2020        PMID: 33333932     DOI: 10.3390/ijms21249546

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  4 in total

1.  Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine.

Authors:  Zhen Ye; Aiying Bing; Shulian Zhao; Shuying Yi; Xianquan Zhan
Journal:  EPMA J       Date:  2022-05-10       Impact factor: 8.836

Review 2.  Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma.

Authors:  Daniël P de Bruyn; Aaron B Beasley; Robert M Verdijk; Natasha M van Poppelen; Dion Paridaens; Ronald O B de Keizer; Nicole C Naus; Elin S Gray; Annelies de Klein; Erwin Brosens; Emine Kiliç
Journal:  Biomedicines       Date:  2022-02-21

Review 3.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

4.  Analysis of Alternative mRNA Splicing in Vemurafenib-Resistant Melanoma Cells.

Authors:  Honey Bokharaie; Walter Kolch; Aleksandar Krstic
Journal:  Biomolecules       Date:  2022-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.